# MondoTwin

> MondoTwin is an AI-powered platform that transforms unexploited academic research into ready-to-license rare disease therapies, connecting the world of science with the world of patients.

MondoTwin bridges the gap between academic researchers with promising rare disease discoveries and pharmaceutical companies seeking de-risked, clinical-stage assets to license.

## Key Pages

- [Home](https://www.mondotwin.com/): Overview of MondoTwin's mission and platform
- [For Researchers](https://www.mondotwin.com/researchers): How MondoTwin helps researchers and institutions advance clinical-stage rare-disease research and introduces it to development partners. No fees for researchers or institutions
- [For Development Partners](https://www.mondotwin.com/pharma): For pharma, biotech, foundations, investors, and public funders searching for clinical-stage rare-disease pipeline
- [About](https://www.mondotwin.com/about): Team, mission, and company background
- [Full Details](https://www.mondotwin.com/llms-full.txt): Comprehensive information about MondoTwin

## Contact

- Website: https://www.mondotwin.com
- Contact: https://www.mondotwin.com/about#contact